Two larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five doses of ...

Tempus AI (NasdaqGS:TEM) has launched the ArteraAI Prostate Test, its first externally developed AI-powered digital pathology test for metastatic hormone-sensitive prostate cancer. The test is ...

U.S. study supports findings from a global trial using an external control arm ...

CHICAGO -- Patients with advanced prostate cancer treated with enzalutamide (Xtandi) had a significantly greater decline in ...

Preview ASCO 2026 late-breaking cancer trials—from TNBC ADC survival gains to lung, liver, prostate and myeloma readouts ...

Getting life insurance after cancer depends on the cancer type, grade, treatment and timing ...

From the foods men eat to how surgery is planned and public awareness unfolds, new research presented at the American Urological Association (AUA) Annual Meeting in Washington, DC, shows prostate ...

GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective ...

Treating breast cancer that has begun to spread around the body with targeted radiotherapy could help patients to live longer ...

Researchers with the James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center have discovered a new ...

Every year, hundreds of thousands of men receive a prostate cancer diagnosis and immediately face a decision that medical ...

Novartis (SWX:NOVN) just put fresh Pluvicto data from the Phase III PSMAddition study in front of urologists, showing ...